Abstract: This study assessed the extent to which sleep-disordered breathing (SDB), difficulty initiating and maintaining sleep (DIMS), and excessive daytime sleepiness (EDS) were associated with impairment of quality of life (QoL) using the SF-36. Participants (n=5,816; mean age=63 years; 52.5% women) were enrolled in the nation-wide population-based Sleep Heart Health Study (SHHS) implemented to investigate sleep-disordered breathing as a risk factor in the development of cardiovascular disease. Each transformed SF-36 scale was analyzed independently using multiple logistic regression analysis with sleep and other potential confounding variables (e.g., age, ethnicity) included as independent variables. Men (11.6%) were significantly more likely to have SDB compared to women (5.6%), while women (42.4%) were significantly more likely to report DIMS than men (32.5%). Vitality was the sole SF-36 scale to have a linear association with the clinical categories of SDB (mild, moderate, severe SDB). However, individuals with severe SDB indicated significantly poorer QoL on several SF-36 scales. Both DIMS and EDS were strongly associated with reduced QoL even after adjusting for confounding variables for both sexes. Findings suggest 1) mild to moderate SDB is associated with reduced vitality, while severe SDB is more broadly associated with poorer QoL, 2) subjective sleep symptoms are comprehensively associated with poorer QoL, and 3) SF-36 mean score profiles for SDB and sleep symptoms are equivalent to other chronic diseases in the U.S. general population.
INTRODUCTION

STUDIES CONTINUE TO INDICATE THAT SLEEP DISOR-DERS ARE PREVALENT IN THE GENERAL POPULATION
AND INCREASE WITH AGE. [1] [2] [3] [4] [5] Overall prevalence rates of disturbed sleep have been estimated to be between 35% to 41% among adults. 1, [6] [7] [8] The most commonly cited sleep problems reported in adult populations include sleep-disordered breathing (SDB) and insomnia. 1, 3, 6, 9 SDB is diagnosed more frequently in men. 10 Insomnia, or difficulty initiating and maintaining sleep (DIMS), is the most frequently reported sleep symptom, particularly by older adults. The prevalence rates for insomnia range from 23-34%, 11 and have been found to be higher in women. 1, [12] [13] Excessive daytime sleepiness (EDS) is a common symptom in adult populations. Recently, 32% of a national survey sample reported that EDS interfered with their daily routine despite adequate sleep the preceding night. 2 EDS has been associated with increased concern because it can lead to travel and work-related accidents, 2,4,14 and can contribute to poorer general health status. 15 Sleep symptoms can be associated with lifestyle changes, such as social patterns, death of loved ones, career, and economic status, as well as comorbid conditions, such as cardiovascular disease, depression, neurological disorders, and disrupted sleep cycles.
Although relationships between sleep problems and health status, lifestyle, and medical economics have received considerable attention 2,6,9,16 few studies have determined associations between SDB, sleep symptoms, and functional quality of life (QoL). 15, 17 Current managed care requirements place greater responsibility on physicians to practice good medicine within the confines of capitated costs, while simultaneously addressing the quality of life issues of their patients as outcome measures. [18] [19] We assessed the extent to which SDB and sleep symptoms (i.e., DIMS and EDS) were associated with diminished QoL using the SF-36 scales as dependent measures in the Sleep Heart Health Study (SHHS) population. Noting that prior research found gender differences in prevalence rates for sleep problems, we hypothesized that there would be differences in men's and women's sleep complaint reports.
METHODS
Subjects are participants in the multi-center Sleep Heart Health Study (SHHS) investigating SDB as a risk factor in the development of cardiovascular disease (CVD). Study design and methods have been previously described in depth. [20] [21] Briefly, the study population includes 6,440 men and women over 40 years of age. Subjects who underwent in-home polysomnography (PSG) to assess the presence of SDB were recruited from the following studies: the Atherosclerosis Risk in Communities Study (ARIC); Cardiovascular Health Study; Framingham Heart Study; Strong Heart Study; New York Hypertension Cohorts; and Tucson Epidemiologic Study of Airways Obstructive Diseases and the Health and Environment Study. Persons with tracheostomy, receiving home oxygen therapy, or being treated for obstructive sleep apnea with continuous positive airway pressure (CPAP) or oral devices were excluded from the study, as any of these conditions could serve as confounds in outcome and/or result in technical difficulties in obtaining in-home PSG.
Demographics, Sleep, Behavioral Health, and Quality of Life Measures
Participants completed demographic data (sex, age, ethnicity, marital status, and education) and the SHHS Sleep Habits Questionnaire (SHQ). 20 The SHQ contained questions regarding sleep habits, smoking status, as well as cardiovascular and respiratory problems and self-reported diabetes. Height and weight were also measured directly to determine body mass index (BMI). Difficulty initiating and maintaining sleep (DIMS) was assessed using the SHHS Sleep Habits Questionnaire. Trouble falling asleep, staying asleep, and early awakening with the inability to return to sleep were rated on a five-point Likert-like scale from "Never" 1 to "Almost Always." 5 The SHQ also measured feelings of excessive sleepiness during the day (EDS), unrefreshing sleep, and use of medications to help with sleep using the same five-point Likert-like scale used to assess DIMS. The Epworth Sleepiness Scale (ESS) was included as the primary measure to assess subjective daytime sleepiness. 22 The ESS, slightly modified in wording for clarity and grammatical correctness for use in the SHHS 20,23 is an eight-item self-administered questionnaire used for rating the likelihood of dozing in eight daily situations on a scale of 0-3. Scores are totaled across the eight items with an ESS score ≥11 used to represent an abnormal level of daytime sleepiness. 24 The ESS is a unitary scale with a Cronbach's alpha of 0.88 and test-retest reliability over five months of r=0.82. 25 The scale can distinguish between patients with excessive daytime sleepiness and normal subjects; it shows a small but significant association with the multiple sleep latency test in some studies, [26] [27] [28] but not others (e.g., 29). Similarly, the ESS score is associated with the rate of apneas and hypopneas in obstructive sleep apnea patients studied by some, 24,27,30 though not all, investigators (e.g., 31).
QoL was assessed using the Medical Outcomes Survey (MOS) SF-36, a health-related quality of life measure. The MOS short form was developed as part of a cross-sectional and longitudinal study of variations in health care practices and outcomes in over 10,000 outpatients. 32 The SF-36 can discriminate between subjects with and without chronic diseases and has excellent internal consistency. [33] [34] [35] The survey is self-administered and assesses eight health dimensions, including: 1) physical activities (PF); 2) social activities (SF); 3) physical health problems (RP); 4) bodily pain (BP); 5) general mental health (MH); 6) emotional problems (RE); 7) vitality (VT); and 8) general health perceptions (GH). Scores for each scale range from 0-100, with higher scores representing better quality of life. Scores are calculated using an SF-36 specific, standardized scoring algorithm, which weights answers from questions pertinent to each scale. The number of questions per scale varies and, so too, does the number of possible scores for each scale. 32 
Polysomnography Evaluation for Sleep-Disordered Breathing
SHHS participants underwent overnight in-home PSG using the Compumedics Portable PS-2 System (Abbottsville, Victoria, AU). The SHHS recording montage consisted of C3/A1 and C4/A2 EEGs; right and left electrooculograms (EOGs); a bipolar submental electromyogram (EMG); thoracic and abdominal excursions (inductive plethysmography bands); "airflow" (detected by a nasal-oral thermocouple [Protec, Woodinville, WA]), oximetry (finger pulse oximetry (Nonin, Minneapolis, MN)), ECG, and heart rate (using a bipolar ECG lead); body position (using a mercury gauge sensor); and ambient light (on/off, by a light sensor secured to the recording garment). Sensors were placed and equipment was calibrated during an evening home visit by a certified technician. Following equipment retrieval, the data, stored in real time on PCMCIA cards, were down-loaded to the computers of each respective clinical site, locally reviewed, and forwarded to a central reading center (CWRU, Cleveland, OH).
Scoring of Polysomnograms
An apnea was defined as a complete or almost complete cessation of airflow (at least <25% of baseline), as measured by the amplitude of the thermocouple signal, lasting ≥10 seconds. Hypopneas were identified if the amplitude of an index of flow or volume (detected by the thermocouple or thorax or abdominal inductance band signals) clearly decreased (but did not meet the criteria of apneas), and were <70% of the amplitude of "baseline" breathing for ≥ 10 seconds. For this study, only apneas or hypopneas associated with at least a 4% desaturation were considered in the calculation of the RDI (RDI 4%). For analysis of binary data, SDB was defined as a Respiratory Disturbance Index (RDI) 4% ≥ 30 (number of apneas of at least 10 seconds duration and hypopneas per hour of total sleep time associated with 4% desaturation). In this study, clinical categories of RDI 4% were defined as mild (5-< 15), moderate (15-< 30) , and severe (≥30) SDB compared to the referent (<5). 24
Statistical Analysis
The distribution of scores for the scales of the SF-36 ranged from 0 to 100 with the number of unique scores per scale varying from 5 to 61. Scores for the Role Emotional, Role Physical, Social Functioning, and Bodily Pain scales had few unique values (5,7,9, and 28, respectively) . In order to analyze data from all scales using consistent methods, scores were dichotomized at the 25th percentile using gender-specific distributions. Scores below the cut point represented poor QoL. The association between poor QoL and each sleep-related variable (SDB, DIMS, and EDS) was modeled independently using standard Logistic Regression techniques. All models were adjusted for age, gender, ethnicity, marital status, body mass index (BMI), smoking status, years of education, taking pills for sleep, and prevalent cardiovascular and respiratory conditions. The Role Emotional scale was not analyzed, as its score did not have sufficient variation to be dichotomized (the 25th percentiles of the scale's scores were already the maximum possible score of 100).
Abnormal daytime sleepiness was defined as scores ≥11 using the Epworth Sleepiness Scale (ESS). 29 Difficulty initiating and maintaining sleep (DIMS), was dichotomized using the fivepoint Likert-like scale for SHQ described above, such that "Almost Always" and "Frequently" represented DIMS; any other response was considered negative. RDI 4% measurements defined SDB. The linear association between increasing SDB and QoL was explored in tandem with the association of severe SDB with QoL. The linear association was modeled in three ways: 1) SDB was defined by RDI 4% as a continuous variable; 2) SDB was defined by RDI 4% quartile indicators, with the lowest quartile as the referent; and 3) SDB was defined by clinical categories of RDI 4% as mild (5 -<15), moderate (15-< 30) , and severe (≥30) SDB compared to the referent (<5). 24 The association of severe SDB with QoL was modeled using its clinical indicator of RDI 4% ≥30. Analyses were conducted using STATA statistical software (StataCorp, 1999) . Odds ratios with 95% confidence intervals were computed from the results of the logistic regression analyses.
RESULTS
Sample Characteristics
Of the 6,440 subjects recruited into the SHHS, 5,816 (90.3%) had complete PSG, SF-36, DIMS, and ESS data for this analysis. Due to concerns within the Native American population regarding the cultural appropriateness of the SF-36 instrument (8 of the 613 American Indian participants completed the measure), data for American Indians was not included in this study. Specific models to address SDB and sleep symptoms with respect to ethnicity and QoL were not included and will be addressed in a separate paper. However, ethnicity was adjusted for in all analyses in this study. Characteristics of the study population are given in Table 1 . Descriptions have been provided for men and women due to differences noted in prevalence rates for objective and subjective sleep problems. Women comprised 52.5% of the sample. Men reported more years of education. More men reported themselves as Non-Hispanic White, whereas the African-and Mexican American groups were comprised of more women. Nearly 18% more men were married, while a higher proportion of women were divorced/separated or widowed. Men were significantly more likely to be past smokers (53.2%) compared to women (34%), while women (56.1%) were significantly more likely to have never smoked compared to their male cohorts (36.2%) in this study. Men were significantly more likely to have a greater frequency of self-reported cardiovascular disease than women. Women, however, were significantly more likely to have a greater frequency of self-reported respiratory disease. Men (8.2%) were also significantly more likely to have self-reported diabetes compared to women (6%).
Prevalence of SDB and Sleep Symptoms in the Studied Population
Prevalence rates for SDB (RDI 4%), DIMS, and abnormal daytime sleepiness, are included in Table 1 . Women were significantly more likely to report DIMS than men (42.4% and 32.5% respectively). There were no significant age differences between men (62.4+11.6 years) and women (63.1+11.4 years) with DIMS. Men were significantly more likely to report abnormal daytime sleepiness (ESS ≥ 11) compared to women (29.6% to 20.4% respectively), and men with abnormal daytime sleepiness were 98 older (63.5+10.4 years) than women (61.8+10.8 years) with abnormal daytime sleepiness, a significant difference (p=0.002). Men were significantly more likely to be classified by PSG into mild, moderate, and severe SDB categories compared to women. Additional analysis (not shown) indicate that women with mild and moderate SDB were older (66.6+10.8 and 67.2+11.3 years respectively) than men with mild and moderate SDB (64.2+10.6 and 64.9 + 10.1 years respectively), both significant differences (mild = p<0.0001; moderate = p<0.05). There were no significant age differences for men and women with severe SDB (64.6+10.8 and 66.6+10.6 respectively). There were no differences in the average amount of nighttime sleep between men and women (seven hours each).
Findings for SDB (RDI 4%)
The linear relationship between SDB and the SF-36 scales was modeled in three ways. First, SDB was modeled using RDI 4% as a continuous variable. Second, SDB was modeled as quartiles of the distribution of RDI 4% values. Third, SDB was defined in the model using indicators for the clinical categories described above. No statistically significant linear trends for the odds of reporting poor QoL with increasing SDB severity were shown for either of the first two models. The third method, using the clinical categories of SDB, showed a significant linear trend for the Vitality scale only (Table 2 ). Using RDI 4%<5 as the referent, participants with mild, moderate and severe SDB were 1.20, 1.41, and 1.77 times more likely to have reported poor QoL for the Vitality scale respectively.
Although the odds of reporting poor QoL were shown to increase solely with the clinical categories of SDB for the Vitality scale, severe SDB (RDI 4% 30+) was significantly and negatively associated with the General Health Perceptions, Physical Functioning, and Social Functioning scales, as well as the aforementioned Vitality scale, as shown in Table 3 . No significant gender differences were seen for these associations.
Findings for DIMS and ESS ≥ ≥11
Logistic regression models reporting the association of the QoL scales with DIMS and an ESS ≥11 are displayed in Tables 4 and 5, respectively. DIMS was significantly associated with all analyzed scales after adjustment for confound variables (p<0.001). Cohort participants reporting DIMS were twice as likely to have poor Mental Health and Vitality scores, and were more likely to report more Bodily Pain, as well as poorer General Table 6 displays the MOS SF-36 scale scores, including percentiles, means and standard deviations, for SHHS participants with severe SDB, DIMS, and EDS compared to the general U.S. population. 36 The normative data were collected from a representative sample (n=2,474) of non-institutionalized men and women ranging in age from 18 to 94 years in the U.S. general population. Statistical significance was determined using an (Table 6 , b and c).
SF-36 Scale Scores for the General U.S. Population
Mean scores for Mental Health were equivalent to the U.S. normative data for DIMS; participants with severe SDB and EDS showed higher (better) mean scores for Mental Health compared to the normative data (Table 6 , c).
SF-36 Scale Score Comparisons of SDB and Sleep Symptoms with Other Chronic Diseases
Comparisons between SHHS subjects with severe SDB, DIMS, and EDS, and three selected disease groups from the Medical Outcomes Study (hypertension, diabetes, clinical depression) from published normative data 36 are displayed in Table 7 . Unpaired t-tests not assuming equal variances were used to determine significance with alpha set at p<0.05. Findings indicate similar numerical profiles for SDB, DIMS, and EDS compared to Hypertension and Type II Diabetes. Participants with any sleep complaint endorsed more Bodily Pain compared to patients with Hypertension. Persons with severe SDB indicated significantly poorer QoL on the Role Physical scale compared to the normative data for hypertension, while persons with DIMS reported significantly poorer QoL on the Bodily Pain and Mental Health scales compared to normative data for both hypertension and diabetes. The Physical Function scores were comparable between all sleep problems and hypertension, and for severe SDB compared to clinical depression. Mean Vitality and Social Function scores for severe SDB, DIMS, and EDS parallel those of the hypertension and diabetes norms, and the SDB and EDS Mental Health scores are also equivalent to those of patients with hypertension and diabetes. Mean scores for clinical depression were generally poorer compared to severe SDB, DIMS, and EDS, as well as to hypertension and diabetes.
DISCUSSION
Sleep, that knits up the ravell'd sleeve of care. . .
William Shakespeare Findings from this study replicate and extend the sleep literature in several ways. The higher prevalence rates for difficulty initiating and maintaining sleep (DIMS) in women and for sleep disordered breathing (SDB) in men support prior studies. 1, 10, [12] [13] Severe SDB (RDI ≥ ≥30), DIMS, and abnormal daytime sleepiness, as measured by an Epworth Sleepiness Scale (ESS) score ≥ ≥11 were strongly associated with reduced quality of life (QoL) on a majority of the SF-36 scales. Additionally, lower levels of SDB (RDI >5 -<30) were associated specifically with poor Vitality. Finally, a majority of the SF-36 mean scale scores for severe SDB and sleep symptoms were not only seen to be significantly reduced compared to the general U.S. population, the mean score profiles for these sleep problems were also noted to be similar to those of other chronic conditions. 36
Sleep-Disordered Breathing
A recent major area of research has been identifying the extent to which various threshold levels of SDB increase morbidity and reduce QoL in the population. Our findings show General Health, Physical Functioning, Vitality, and Social Functioning to be negatively associated with higher levels of SDB (RDI ≥30). At lower levels of SDB, associations were observed only on the Vitality scale. This is consistent with previous studies of nonclinic populations with mild to moderate levels of SDB, 15 and emphasizes that even low levels of SDB may be adversely associated with selected components of health-related QoL. The four questions that comprise the Vitality scale assess pep, energy, and feeling worn out and tired. 36 Hence, the mild and moderate SDB may be best reflected on this particular SF-36 scale.
These findings do differ somewhat from those of Finn et al., 37 with the SF-36 scales as the dependent measure. Based on the similarity in endpoints for SDB and QoL between the studies, we analyzed our data identically to the Wisconsin Sleep Cohort paper for comparative purposes. Table 8 presents data for both studies. The Wisconsin cohort is considerably smaller, younger, and has fewer women than the SHHS. It is also more racially homogeneous, as no racial adjustment was made in the data modeling. The Wisconsin results suggest that significant linear associations exist between SDB and the Mental Health, Vitality, Physical Functioning, Social Functioning, Role Physical, and General Health SF-36 scales. In contrast, however, linear models constructed with the SHHS data only show a significant association between SDB and the Vitality scale. Possible reasons for the discrepancy between the results in the two studies may lie in the validity of ordinary least squares linear regression analysis with SF-36 scales as dependent variables. Although each of the scales is scored to give values from 0 to 100, three of the eight scales have distributions of scores that are ordinal rather than continuous (the Role Emotional, Role Physical, and Social Functioning scales have 5, 7, and 9 unique values respectively). Therefore, the inherent assumption necessary for linear regression, that the dependent variable is continuous, would be violated in these cases. Dichotomizing the distribution of scores at a cut point easily overcomes this issue, and standard analytical techniques, such as logistic regression, can be used to model the association of covariates with the binary outcome. Despite differences in findings, however, both studies concur that SDB is negatively associated with QoL specific to the Vitality scale.
Sleep Symptoms-DIMS
Overall men and women with self-reported DIMS showed reduced QoL on the Mental Health, Vitality, Bodily Pain, General Health, Social Functioning, Role Physical, and Physical Functioning scales of the SF-36. These scales reflect frequent feelings of nervousness and depression; reduced energy and frequent tiredness; pain that limits activities of daily living (ADLs); poorer perceived personal health; frequent and extreme interference with everyday social activities due to emotional or physical complaints; difficulty with work or other activities; and limited performance of physical activities, such as bathing or dressing. The prevalence of DIMS was significantly higher for women, indicating that poorer QoL is associated with DIMS for greater numbers of women than men. Interestingly, in a recent report of sleep disturbances in children 3 to 14 years of age, Camhi et al. 38 found that the prevalence of DIMS in 11 to 14 year old girls approached that of adult women, suggesting an adolescent onset of DIMS in women. Camhi et al. 38 also found that DIMS in children was related to presence of respiratory disease, as in adults. 1, 12 Notably, women with DIMS (8.6%) in this study have a higher prevalence rate of chronic bronchitis than men with DIMS (6.4%) (p=0.05). Given the large number of women reporting DIMS, and its negative association with QoL, future longitudinal studies should assess the natural course of DIMS in girls and women.
Sleep Symptoms-EDS
A significant interaction was noted for men and women with The remaining QoL scales were comprehensively negatively associated with ESS ≥ ≥ 11 for both men and women. The negative association between QoL and EDS underscores the need to address this common symptom in the adult population. However, measures used to assess EDS in future studies also need to be carefully considered. In this analysis, we chose the ESS as a measure of subjective sleepiness as it recently has been the most commonly used measure in similar studies. 24 We noted gender differences in prevalence rates for EDS (23.8% in women; 19.2% in men, p<0.05) as defined by other items on the SHQ regarding daytime sleepiness, however. This finding suggests reduced concordance between the ESS and the SHQ EDS measures. Future studies will need to address these measurement issues to more adequately and appropriately assess sleepiness and gender, particularly in view of the fact that EDS has traditionally been strongly associated with SDB, 24,27 a sleep disorder more common in men.
SDB, Sleep Symptoms, and Normative Data
To our knowledge, this is the first study to report comparisons of SDB and sleep symptoms with published normative data from the Medical Outcomes Study. 36 In general SHHS participants with severe SDB, DIMS, or EDS indicated significantly poorer QoL on the Physical Functioning, Role Physical, Bodily Pain, General Health, and Vitality scales compared to the general U.S. population. These findings suggest that persons with sleep problems experience greater difficulty in performing everyday activities, such as bathing and grocery shopping, role limitations at home and work, more bodily pain, reduced energy levels, and perceive their overall health to be poorer compared to the general U.S. population. Further, several of the mean scale scores for SDB, DIMS, and EDS parallel those of published normative data for other chronic conditions, 36 particularly hypertension and Type II diabetes.
Conclusions
Taken together, these data indicate that SDB and sleep symptoms are associated with poorer QoL. SDB may not be broadly associated with poorer QoL until it has become moderate to severe, although the Vitality scale may be indicative of the strength of the association between SDB and QoL during the natural history of the disorder.
Currently, it is not clear whether functional impairments in SDB are best attributable to sleep-associated hypoxemia, increased breathing effort, or to sleep fragmentation. The exposure variable used in this paper was the RDI 4%, which provides a general indication of both the frequency of respiratory events as well as the degree of intermittent desaturation and arousal. The RDI was chosen for use in this paper as it provides a highly reproducible index that is commonly used to classify disease severity. 39 This RDI has been shown to be highly correlated with other commonly used RDIs, defined using different criteria for linked desaturation and arousal. 40 The absolute magnitude of RDI may vary substantially with RDI definition, however, and one should be careful when extrapolating findings from this study to other settings that potential differences in cutoff values are considered. Future studies should also systematically assess which SDB indices (desaturation profiles, arousal indices, etc.) are most strongly predictive of functional impairment. Further, in view of the fact that the SF-36 is a general measure of functional QoL, future studies may also benefit from the use of measures specific to SDB and QoL, such as those proposed by Flemons [41] [42] and Weaver. 43 The intent of this study was to provide associations between sleep symptoms (DIMS and EDS), as well as SDB with QoL. Other potential explanations for the observed associations in this study include other comorbid conditions for which we did not control, or a tendency for some participants to rate their sleep, or their QoL more poorly on the survey instruments. One reason that DIMS and EDS may have been associated with reduced QoL of similar magnitude to other health conditions reported by Ware 36 is that SHHS participants with DIMS or EDS may have had some of those conditions. Insomnia and sleepiness symptoms are strongly associated with medical and psychiatric disorders, including depression. 6, 9, 12, [14] [15] 17 The participants with insomnia symptoms in this study, for example, very likely included persons with disorders of insomnia related to depression, insomnia due to medical conditions, as well as primary or psychophysiological insomnia. Further research is needed to address specific causes of DIMS and EDS and their associations with QoL in specific patient groups. Despite any limitations, the descriptive data from this study can serve as a springboard for future investigations of this type. These findings also underscore the point that future studies of SDB, sleep symptoms, and QoL research need to differentially address gender, as well as ethnicity. Further, in light of the mean scale score findings noted between severe SDB, DIMS, and EDS with U.S. normative data, the impact of disordered sleep on QoL may currently be underestimated. Combined, results from this study can be extrapolated to the clinical setting to suggest that patient assessment should include sleep complaints of men and women as standard part of primary care. The additional patient information may prove fruitful in reducing sleep-related comorbidities, while simultaneously enhancing patient satisfaction and quality of life.
